AWM
IDXX icon

Aevitas Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Aevitas Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-132
Closed -$29K – 198
2019
Q1 		$29K Sell
132
-16
-11% -$3.3K 0.03% 229
2018
Q4 		$28K Hold
148
– – 0.03% 217
2018
Q3 		$37K Hold
148
– – 0.03% 225
2018
Q2 		$32K Hold
148
– – 0.03% 234
2018
Q1 		$28K Hold
148
– – 0.03% 225
2017
Q4 		$23K Buy
+148
New +$23.3K 0.02% 245

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Aevitas Wealth Management's IDXX Position: Q2 2019 in Review

Aevitas Wealth Management sold out of Idexx Laboratories (IDXX) in Q2 2019, closing a stake of 132 shares — an estimated $29K sold.

Aevitas Wealth Management first reported a position in IDXX in Q4 2017 and held it in 6 quarters. The position peaked at $37K in Q3 2018. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.

  • Aevitas Wealth Management reported no remaining Idexx Laboratories position as of Q2 2019 after selling out during the quarter.
  • Aevitas Wealth Management sold 132 Idexx Laboratories shares in Q2 2019, an estimated $29K.
  • Aevitas Wealth Management first reported a position in Idexx Laboratories in Q4 2017 and held it in 6 quarters.
  • Aevitas Wealth Management's Idexx Laboratories position peaked at $37K in Q3 2018.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.

Based on Aevitas Wealth Management's 13F filing for Q2 2019, filed 26 Jul 2019.